Sun Pharma Q4FY18E Result Expectation
Sun Pharma is expected to report weak numbers in Q4; commentary on the US business, especially the Halol plant, will be keenly observed.
from India Infoline News Service https://ift.tt/2KOtZ9U
from India Infoline News Service https://ift.tt/2KOtZ9U
Comments
Post a Comment